Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Congress Seeks Third-Party Assessment Of FDA’s Budget

Executive Summary

The FDA Science Board panel that recently assessed the state of science at the agency is well-equipped to quantify FDA's resource needs, according to its chairwoman

You may also be interested in...



FY 2009 Approps Package Will Likely Need To Wait For Next Administration

House Democratic leaders are signaling an intention to put off finalizing fiscal 2009 appropriations at least until next March, charging Republican members of Congress and the Bush administration are impeding negotiations on mutually agreeable bills

FDA Budget Needs To Double Over Next Five Years, Science Board Says

The FDA Science Board has recommended a $375 million increase over fiscal 2008 in direct appropriations to FDA for 2009, and larger increases in each of the following five federal budgets

FDA Budget Needs To Double Over Next Five Years, Science Board Says

The FDA Science Board has recommended a $375 million increase over fiscal 2008 in direct appropriations to FDA for 2009, and larger increases in each of the following five federal budgets

Related Content

UsernamePublicRestriction

Register

PS049282

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel